Search results
Bull Market and Beyond: 2 Stocks Just Waiting to Soar | The Motley Fool
The Motley Fool· 20 hours agoLet's consider two such stocks: Moderna (MRNA 7.13%) and DexCom (DXCM -1.65%). Moderna is one of the...
FDA delays decision on Moderna RSV vaccine
BioPharma Dive via Yahoo Finance· 4 days agoThe regulator cited “administrative constraints,” rather than any issue with Moderna’s trial data, for missing a May 12 deadline, the company said.
Bull Market and Beyond: 2 Stocks Just Waiting to Soar
Motley Fool via Yahoo Finance· 20 hours agoThough it might be tempting to invest in stocks that have largely been in tandem with the broader...
Unveiling Moderna (MRNA)'s Value: Is It Really Priced Right? A C
Guru Focus· 17 hours agoModerna Inc (MRNA, Financial) has recently shown a notable daily gain of 5.55%, with a three-month gain of 34.21%. Despite these impressive numbers, a deeper look into the ...
Moderna Announces Update on Investigational RSV Vaccine
Morningstar· 4 days agoCAMBRIDGE, MA / ACCESSWIRE / May 10, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced it has been notified by the U.S. Food and Drug Administration (FDA) that due to administrative ...
Moderna Stock Seesaws After The FDA Throws It A Curveball
Investor's Business Daily· 4 days agoThe FDA was due to make a decision by May 12. Moderna emphasized the FDA has not said it found any...
Positive week for Moderna, Inc. (NASDAQ:MRNA) institutional investors who lost 6.8% over the past...
Simply Wall St. via Yahoo Finance· 5 days agoKey Insights Significantly high institutional ownership implies Moderna's stock price is sensitive...
If You'd Invested $1,000 in Moderna Stock 5 Years Ago, Here's How Much You'd Have Today
Motley Fool via Yahoo Finance· 5 days agoFive years ago, pharmaceutical company Moderna (NASDAQ: MRNA) was mostly unknown. It was developing...
Moderna’s mRNA dreams meet reality with first post-COVID shot - The Boston Globe
The Boston Globe· 4 days agoModerna’s stock dropped 45 percent last year, making it the worst-performing large biotech in the...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 6 days agoModerna stock broke out for the first time in over a year on May 2 after the biotech company notched...